Product image of Moxifloxacin Sandoz (Moxifloxacin) supplied by GNH India

Moxifloxacin Sandoz

Active Ingredient:
Moxifloxacin
Origin:
EU

Moxifloxacin Sandoz (Moxifloxacin)

Moxifloxacin, the active ingredient in Moxifloxacin Sandoz, is a fluoroquinolone antibiotic presented as an oral tablet for systemic use. It treats a range of serious bacterial infections in adult patients, including pneumonia, sinusitis, bronchitis and skin infections.

GNH India supplies Moxifloxacin Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Sandoz N.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Moxifloxacin is a broad‑spectrum fluoroquinolone used to treat bacterial infections of the respiratory and skin pathways.

  • Community‑acquired bacterial pneumonia: eradicates susceptible pathogens and improves respiratory function.
  • Acute bacterial sinusitis: reduces sinus inflammation and clears infection.
  • Acute bacterial exacerbation of chronic bronchitis: shortens disease course and prevents complications.
  • Skin and skin structure infections: eliminates causative bacteria and promotes wound healing.

How It Works

  • Moxifloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA replication, transcription and repair. By binding to these enzymes, it prevents the supercoiling and separation of bacterial DNA, leading to bacterial cell death and a bactericidal effect against susceptible Gram‑positive and Gram‑negative organisms.

Side Effects

Moxifloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: loose stools, sometimes watery.
  • Headache: transient cranial discomfort.
  • Dizziness: sensation of light‑headedness.
  • Abdominal pain: cramping or discomfort.
  • Rash: mild skin redness or itching.

Serious or Rare Side Effects

  • Tendon rupture: sudden tendon pain or loss of function.
  • QT interval prolongation: risk of cardiac arrhythmias.
  • Severe allergic reactions: anaphylaxis, swelling, or hives.
  • Clostridioides difficile infection: severe colitis.
  • Hepatic toxicity: elevated liver enzymes or jaundice.
  • Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement.

Precautions & Warnings

Before prescribing Moxifloxacin, clinicians should consider several safety factors.

  • Renal impairment: assess kidney function and adjust therapy if needed.
  • History of tendon disorders: avoid use in patients with prior tendon injury.
  • QT prolongation risk: monitor ECG in patients with cardiac risk factors.
  • Pregnancy and lactation: reserve for situations where benefits outweigh potential risks.
  • Concomitant medications: review for interactions that may increase toxicity.
  • Store at below 25°C: keep in the original pack, protect from moisture and direct sunlight.

Avoid Interactions

Moxifloxacin can interact with other medicines, requiring careful management.

Major Interactions (Avoid)

  • Other fluoroquinolones (e.g., ciprofloxacin): additive toxicity.
  • Antacids containing magnesium or aluminum: markedly reduce absorption.
  • Warfarin: increased anticoagulant effect and bleeding risk.

Moderate Interactions (Monitor Closely)

  • Corticosteroids: heightened risk of tendon rupture.
  • Theophylline: elevated serum concentrations leading to toxicity.
  • Diabetes medications: possible alterations in blood glucose control.

Frequently Asked Questions

Moxifloxacin Sandoz is indicated for adult patients with community‑acquired bacterial pneumonia, acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and skin or skin‑structure infections caused by susceptible bacteria.

Moxifloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes needed for DNA replication and transcription. This inhibition prevents bacterial DNA from unwinding and re‑winding, leading to bacterial cell death and a bactericidal effect.

The prescribed dose of Moxifloxacin Sandoz is determined by the treating physician based on the specific infection, patient characteristics and local guidelines. Patients should follow the exact regimen provided by their healthcare professional.

The safety of Moxifloxacin Sandoz in pregnancy or lactation has not been definitively established. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and under close medical supervision.

To request Moxifloxacin Sandoz, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Moxifloxacin offers a broader spectrum against Gram‑positive organisms and better activity in respiratory infections compared with many older fluoroquinolones. It also has a once‑daily dosing schedule, but like all fluoroquinolones it shares class‑related safety considerations such as tendon risk and QT prolongation.

Moxifloxacin Sandoz tablets should be stored at or below 25 °C, in the original packaging, protected from moisture and direct sunlight. Do not store in humid environments or expose to excessive heat.

Moxifloxacin Sandoz is taken orally, usually as a tablet, with or without food as directed by the prescriber. The tablet should be swallowed whole with water and not chewed or crushed unless specifically instructed.

Serious risks include tendon rupture, especially in the Achilles tendon, QT interval prolongation that can lead to cardiac arrhythmias, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome.

Patients with a known hypersensitivity to moxifloxacin or any fluoroquinolone should avoid the drug. It is also contraindicated in individuals with a history of tendon disorders related to fluoroquinolone use, those with significant QT prolongation, and patients receiving concomitant drugs that strongly interact without appropriate monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Moxifloxacin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT